| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |